---
schema_version: "secwatch.filing_event.v1"
accession: "0000080424-23-000114"
form_type: "8-K"
ticker: "PG"
cik: "0000080424"
company_name: "PROCTER & GAMBLE Co"
filed_at: "2023-12-13T23:59:59+00:00"
generated_at: "2026-06-07T13:50:48.367269+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# P&G appoints former J&J MedTech head Ashley McEvoy to board effective Dec 12

## Summary
- Ashley McEvoy, former EVP Worldwide Chairman of MedTech at J&J, appointed to P&G Board effective December 12, 2023.
- McEvoy led J&J's $27B medical devices segment and deployed over $20B in M&A.
- She will serve on Compensation & Leadership Development and Innovation & Technology Committees.
- McEvoy is independent under NYSE standards and receives standard non-employee director compensation.
- Appointment deepens board expertise in global consumer health care and innovation.

## SEC filing metadata
- accession: 0000080424-23-000114
- form_type: 8-K
- ticker: PG
- cik: 0000080424
- company_name: PROCTER & GAMBLE Co
- filed_at: 2023-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/80424/000008042423000114/0000080424-23-000114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/80424/000008042423000114/mcevoyannouncement.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000080424-23-000114
- JSON: https://secwatch.observer/filing/0000080424-23-000114.json
- Plain text: https://secwatch.observer/filing/0000080424-23-000114.txt

## Key facts
- Executive change
  Ashley McEvoy was appointed as Director at PROCTER & GAMBLE Co.
  - Action: appointed
  - Role: Director
  source text: On December 12, 2023, the Board of Directors of The Procter & Gamble Company (the “Company”) appointed Ashley McEvoy, former Executive Vice President, Worldwide Chairman of MedTech at Johnson & Johnson, as a Director of the Company, effective December 12.
  evidence_url: https://www.sec.gov/Archives/edgar/data/80424/000008042423000114/0000080424-23-000114-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.